Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nutrient excess, often termed overnutrition or metabolic overload, is a physiological and pathological state characterized by a chronic surplus of energy intake relative to energy expenditure. This condition leads to the sustained over-activation of nutrient-sensing pathways, most notably the mechanistic target of rapamycin complex 1 (mTORC1), and the concomitant suppression of energy-sensing catabolic pathways, such as those governed by AMP-activated protein kinase (AMPK) [1, 2]. At the cellular level, persistent nutrient excess causes mitochondrial dysfunction, endoplasmic reticulum stress, and the accumulation of toxic lipid intermediates like diacylglycerols and ceramides, which collectively impair insulin signaling [1, 3, 7]. Clinically, it serves as the fundamental driver of the global metabolic disease epidemic, encompassing obesity, type 2 diabetes mellitus, and non-alcoholic fatty liver disease (NAFLD) [10]. While 'nutrient excess' is not a single molecular target, therapeutic interventions for its associated diseases typically involve pharmacological agents that mimic a low-energy state, modulate nutrient-sensing nodes, or enhance insulin sensitivity [5, 7, 8].
Activation of catabolic regulators (e.g., AMPK activation) or inhibition of anabolic drivers (e.g., mTORC1 inhibition) to mitigate the systemic effects of chronic over-nutrition.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nutrient excess.